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Abstract
Background: Infants with Robin sequence (RS) suffer from upper airway obstruction (UAO) and feeding problems.
We developed an oral appliance with a velar extension in combination with functional treatment and appropriate
feeding techniques, which was proven effective in isolated RS. As the above problems are particularly challenging
in syndromic RS, we set out to evaluate our treatment concept also in these patients.
Methods: We searched our electronic departmental database to identify all children admitted to our department
between 01/01/2003 and 31/12/2009 because of syndromic RS. UAO was quantified by cardiorespiratory sleep
studies performed before and during treatment with a modified palatal plate. This appliance consists of a palatal
part, covering the hard palate as well as the alveolar ridges and the potential cleft, and a velar extension shifting the tongue
in a more anterior position, thereby opening the pharyngeal airway. It is adjusted by fiberoptic nasopharyngoscopy and
controlled by cardiorespiratory sleep studies. Obstructive sleep apnea was defined as a mixed obstructive sleep apnea index
(MOAI) >3/h. Feeding modalities before and after treatment and weight gain, determined as standard deviation score, were
also evaluated.
Results: Of 68 children meeting inclusion criteria, 56 completed treatment (46 of these being infants). Underlying diagnoses
included craniofacial dysostosis (N= 13) and synostosis syndromes (N= 5), unspecified dysmorphic syndromes (N= 23) and
miscellaneous rare conditions (N= 27).
Median MOAI decreased from 8.5 (range 0.3–76.0) at admission to 1.1 (0.0–5.2) at discharge (p < 0.001). 51 children
received only a TPP and 5 additionally continuous positive airway pressure (CPAP) or high-flow nasal cannula during
sleep for mild residual OSA. Three children ultimately required tracheostomy. The number of exclusively gavage fed
infants was reduced from 23 to 7. Conversely, the number of children fed exclusively by mouth increased from 18 to
30. Median SDS for weight decreased from −1.6 (−3.5–1.7) to −1.3 (−4.1-2.5). Twelve children had their treatment
prematurely discontinued, e.g. due to laryngeal collapse/laryngomalacia. No patient died during treatment.
Conclusion: Treatment of UAO and feeding problems in these children with syndromic RS by a modified palatal plate
with a velar extension was shown to be effective and safe. If confirmed in prospective studies, it may help to avoid
more invasive interventions.
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Background
Robin Sequence (RS) is characterized by micrognathia,
glossoptosis and respiratory distress; a U-shaped cleft
palate may also occur [1]. Its incidence ranges from
1:8500 to 1:14500 live births [2, 3]. An epidemiological
study determined a birth prevalence of 12.4 per 100.000
live births in Germany [4]. Recently, recommendations
for the initial evaluation of RS and clinical descriptors
were published in a consensus report [5].
The main clinical problems in RS include upper airway
obstruction (UAO), feeding difficulties and failure to
thrive, potentially leading to neurocognitive impairment,
behavioral difficulties, pulmonary hypertension, congest-
ive heart failure and sudden death [6]. Feeding problems
and failure to thrive may be secondary to respiratory
problems, i.e. an increased work of breathing [7], but
may also be due to swallowing dysfunction [8] and
abnormal sucking quality [9], leading to a low calory in-
take, pulmonary aspiration, and gastro-esophageal reflux.
Interventions for children with RS should thus be
assessed by their ability to improve respiratory problems
and weight gain.
RS may occur both, as an isolated entity (isolated RS)
or as a component of a syndrome, i.e. in association with
other malformations (syndromic RS). More than 50 syn-
dromes have been described in association with RS [10],
the most common being Stickler syndrome, Nager syn-
drome, Treacher Collins syndrome and 22q11 deletion
(velocardiofacial syndrome) [11]. In a recent study, 40%
of RS cases were isolated and 60% syndromic [12]. Thus,
failure to thrive in RS may also be caused by an under-
lying syndromic condition [13].
Endoscopically, 4 types of UAO can be differentiated
[14], of which a so-called type 1 UAO (i.e., true glossop-
tosis) is found in 90% of patients with isolated RS, but in
as little as 44% of those with syndromic RS [15]. Treat-
ment of UAO in RS should stabilize the pharyngeal wall
and widen the hypopharynx by shifting the tongue into a
more anterior position, thereby facilitating oral feeding
and stimulating mandibular growth. Most current treat-
ment options, however, fail these aims or are consider-
ably invasive [16].
In our centre, an oral appliance (Tübingen Palatal
Plate (TPP) or pre-epiglottic baton plate) (Fig. 1a) in
combination with Manual Orofacial Therapy (MOT)
according to Castillo-Morales [17] and appropriate
feeding techniques are used as a first line treatment
option for infants with RS and UAO. The TPP consists
of a plate with a velar extension that shifts the tongue
forward, thereby widening the hypopharynx and
releasing the UAO. This treatment concept has been
successfully evaluated in infants with isolated RS
[18, 19], but little is known whether it is equally ef-
fective in syndromic RS.
The aim of this study was to evaluate our treatment
approach in the latter patient group, again focusing on
UAO and feeding problems. Because of their more com-
plex anatomical and functional disturbances, modifica-
tions to the original TPP were often necessary, which
will also be described here.
Methods
Patients
The department’s electronic patient database (Neodat®,
Tübingen, Germany) was searched for all children with a
diagnosis of syndromic RS admitted to the Department
of Neonatology at Tübingen University Hospital between
01/01/2003 and 31/12/2009. Children with isolated RS
or Down syndrome were excluded. In total, of 68 chil-
dren (29 females) meeting inclusion criteria, 12 had
treatment discontinued for various reasons (see below),
so that data were analyzed for 56 children completing
treatment.
Study design and procedures
All patients underwent orthodontic treatment by TPP in
combination with MOT and an intensive feeding train-
ing. They also had sleep studies performed upon admis-
sion, after fitting the TPP and after each modification of
the plate. The following clinical data were collected:
underlying diagnoses, age, gender, body weight, length,
head circumference, type of cleft, treatment prior to
admission, feeding modalities before and after treatment
with the TPP as well as type of palatal plate used and
sleep study results.
Fig. 1 Various types of palatal plates used in these patients: a classical
Tübingen palatal plate; b modified plate with a ring or c a tube
attached to the extension; d modified plate with a tube that has an
extra-oral extension
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Sleep studies
Sleep studies were performed using a computerized
system (Embla N 7000, MedCare, Reykjavik, Iceland).
The study montage comprised the following channels
and sensors: chest and abdominal wall movements
(respiratory inductive plethysmography, MedCare),
nasal pressure and linearized nasal airflow (nasal
prongs and built-in pressure transducer, MedCare),
pulse oximeter saturation (SpO2) and pulse wave-
form (Radical, Masimo Inc., Irvine, USA), electrocar-
diography (ECG, MedCare), and digital video via
infrared camera (Panasonic; Tokyo, Japan). Record-
ings commenced in the evening and lasted for at
least 8 h; all infants were studied in the supine
position.
All recordings were manually analyzed by a trained
scorer not involved in clinical management and
blinded to their timing (before/after treatment) for
the presence of respiratory events using standard cri-
teria [20]. In brief, total sleep time (TST) was deter-
mined from the first 10-min epoch without
movement artifact or a distorted pulse waveform to
the last such 10-min epoch; recordings comprising
less than 3 h of TST were excluded. An apnea was
scored if (i) the amplitude of the nasal airflow fell to
<20% of the average amplitude of the two preceding
breaths, (ii) no airflow was detected at the mouth,
and (iii) the event comprised at least two breath cy-
cles (i.e. approximately 3–4 s). An obstructive apnea
(OA) was scored if (i) the above criteria for apnea
were fulfilled and (ii) out-of-phase movements of the
chest and abdomen were present. A central apnea
was scored if (i) criteria for apnea were fulfilled and
(ii) no chest and abdominal wall movements were
present. Mixed apneas were defined as those with
both a central and obstructive component, each last-
ing at least two breath cycles. A mixed obstructive
apnea index (MOAI) was calculated as the sum of
mixed apneas plus OA per hour of TST. To comply
with our previous studies on this patient group, ob-
structive sleep apnea (OSA) was defined as a mixed-
obstructive apnea index (MOAI) >3. Infant polysom-
nography has a high validity and reproducibility [21].
Desaturation events were visually confirmed to ex-
clude spuriously low values. Events with a distorted
pulse waveform signal within 7 s prior to their onset
were considered artifactual and excluded. The number
of desaturation events to ≤80% SpO2 was counted
and expressed as indices, defined as events per hour
of TST (DI80).
Treatment protocol
After diagnosis, children were admitted and monitored
in the neonatal intermediate care unit where they also
underwent a baseline cardiorespiratory sleep study and
fiberoptic nasopharyngoscopy without sedation to assess
the type and localization of the UAO. This endoscopy
usually took only 4–5 min, although we never measured
this systematically.
Next, infants had a maxillary imprint taken using a
custom-made impression tray and alginate (Tetrachrom-
Super-Alginat, ISO 1563, Klasse B, Typ I, Kaniedenta,
Herford, Germany). This imprint covered the entire hard
palate, the alveolar ridges and the vestibule. This procedure
was carried out in the neonatal intermediate care unit
under cardiorespiratory monitoring without sedation, but
with a nasopharyngeal airway in place and in the presence
of an experienced neonatologist. Then a plaster cast was
produced using high precision dental plaster (Girodur Type
IV, Synthetic Superhard Stone Plaster for Sectioned and
Master Models DIN EN 26873, white, Girrbach Dental
GmbH, Pforzheim, Germany). Using this cast, appliances
were made from hard acrylic (autopolymerizing methyl-
methacrylate, Orthocryl, Dentaurum, Pforzheim, Germany).
The TPP consisted of a palatal part that covered the hard
palate and the cleft as well as the alveolar ridges and a velar
extension of approximately 3 cm in length. The shape of
the velar extension was modeled from dental wax and
attached dorsally to the plaster cast. The length and the
angle of the extension were chosen so that it was adjacent
to the dorsum of the tongue. It was manufactured using a
blue color to facilitate endoscopic evaluation in situ. After
polymerization this prototype was polished using standard
techniques (Fig. 2).
Once a prototype of the plate was ready, infants had a re-
peat endoscopy to adjust the length and angle of the velar
extension. The tip of the extension descended down to the
vallecula epiglottica and the angulation was responsible for
the anterior shifting of the base of the tongue, erecting the
epiglottis thereby widening the airway. If the airway
appeared endoscopically (Fig. 3) and clinically open, the
prototype was finished, a strengthening wire incorporated
into the extension to safeguard the device against mechan-
ical failure and extraoral wires were added to improve re-
tention of the plate (Fig. 4). Two days later, its effectiveness
was assessed by a second sleep study. If this sleep study still
showed a MOAI >3, the plate was modified: if compression
of the soft palate against the pharyngeal wall by the tongue
or an inward movement or collapse of the pharyngeal walls
and circular constriction of the pharynx was seen, a ring or
a perforated tube with or without an extraoral extension
were attached to the velar extension (Fig. 1 b-d). Again,
effectiveness of the modified plate was controlled endo-
scopically followed by a sleep study. Treatment also
comprised appropriate feeding techniques (finger feeding
and Playtex Drop-Ins®, Playtex Products) and an orofacial
stimulation therapy according to Castillo Morales. Usually,
plates are also worn during feeds.
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In infants and during the first 2–3 months of treat-
ment, appliances are recommended to be worn for 24 h
a day and are removed only 1x/day for cleaning pur-
poses. Depending on the (subjective) degree of
mandibular catch-up growth, they are then only worn at
nighttime. Fitting the plate usually takes less than 10s.
The appliances are held in situ by adhesion and suction
and by an adhesive cream (Blend-a-dent Super Haft-
creme, Procter & Gamble, Schwalbach, Germany) to
improve retention. The extraoral bows are fixed to the
face with adhesives (Steri-Strip, 3 M Helath Care, St.
Paul, MN). Fitting of the plate is controlled at each out-
patient visit. If the palatal part becomes too small a new
TPP has to be adapted. After discharge, the patients are
seen at intervals of 6 to 8 weeks at the orthodontic out-
patient clinic; a further sleep study is mandatory
3 months after discharge. In general, a new plate is ne-
cessary after 3 months in infancy or if a notch appears
on the alveolar ridges, due to a then too small palatal
part of the TPP or if sleep study results deteriorate.
Statistical analysis
Results are reported as median and range. Comparisons
between sleep study results were done using software
(Statistical Package for the Social Science, Version 18,
IBM, New York, USA). For the analysis of sleep parame-
ters, the Wilcoxon signed rank test was used.
Results
Out of 68 children meeting inclusion criteria, 12 had
TPP treatment discontinued prematurely (Fig. 5): in 4
cases TPP proved not to be indicated (two had no upper
airway obstruction but only central sleep apnea, the
other 2 had laryngeal collapse/laryngomalacia). In one
case parents were non-compliant and ultimately refused
TPP treatment, and 5 children did not tolerate the plate
(2 were diagnosed with CHARGE association, and one each
with Dandy-Walker-syndrome, Beckwith-Wiedemann syn-
drome and a severe phenotype of Treacher Collins syn-
drome subsequently requiring tracheostomy. One child was
transferred to the local department of cardiology and also
underwent tracheostomy there. A third child underwent
tracheostomy soon after admission because of recurrent
severe respiratory distress unresponsive to palatal plate
Fig. 2 Fabrication of a prototype of the plate: left, impression tray
and imprint, right, plaster cast and molding of the velar extension,
resulting in the prototype (bottom left)
Fig. 3 Endoscopic views of the plate in situ: right, a classical TPP, left, a TPP with a tube attached to the extension (to prevent the laryngeal structures
from collapsing). 1) tongue, 2) epiglottis, 3) posterior pharyngeal wall, 4) aryepiglottic folds, 5) vallecula, 6) spur/tube of the TPP
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therapy. Thus, 3 out of 68 patients (4%) required tracheos-
tomy; no patient died.
Of the remaining 56 children (35 males), 46 were in-
fants, 31 of them being referred within the first 3 months
after birth, while the remaining were between 2 and
12 years old at admission.
Underlying diagnoses (Table 1) included craniofacial
dysostoses (N = 13) and synostosis syndromes (N = 5)
but many patients (N = 23) had an unspecified dys-
morphic syndrome or were suffering from one of a
variety of extremely rare conditions (N=27) (Tables 1
and 2).
Concerning cleft palate, 30 children did not have any
cleft, whereas 16 had a cleft of the hard and soft palate,
6 presented only a cleft of the soft palate, and 3 had a
submucosal cleft. In one case cleft repair had been done
elsewhere prior to referral.
Upon admission to our department, most children had
already received treatment for UAO, e.g. a nasopharyn-
geal tube or endotracheal intubation, glossopexy, trache-
ostomy, nasal positive pressure ventilation or nasal
cannula oxygen, conventional palatal plates or adenot-
omy (Table 3). Five patients, in addition to nasopharyn-
geal intubation, temporarily needed continuous positive
airway pressure (CPAP) or high-flow nasal cannula
(HFNC) support, and one child with glossopexy had
initially received a nasopharyngeal airway. In 3 children
a transitory switch from nasal cannula oxygen to CPAP
was necessary. However, in 25 patients (mostly
<3 months of age), no specific treatment for UAO had
been initiated prior to admission.
To treat UAO, 4 types of plates were constructed
depending on the type of obstruction. The classical TPP
(Fig. 1a) turned out to be sufficient in 33 patients.
Twenty-three children needed a modified plate to
resolve UAO: 3 required a plate with a ring (Fig. 1b) and
20 with a tube of different length attached to the velar
extension, i.e. an oropharyngeal airway plate (Fig. 1c, d).
At discharge, 51 out of the 56 children who completed
treatment received only a (modified) TPP. Of the remaining
patients, 1 received support via CPAP and 4 HFNC at night
in addition to TPP treatment, because they still had had a
MOAI >3. The 3 children who already had a tracheostomy
in place at referral all had their tracheostomy closed prior
to hospital discharge.
Sleep study results
At baseline, all but 2 patients presented with obstructive
sleep apnea, while 2 had central sleep apnea only.
During treatment, sleep study results improved signifi-
cantly in all parameters analyzed (Table 4).
Fig. 4 Orthodontic appliance (TPP) in situ with extraoral wires to secure optimal position. (Photographs shown with parental permission)
Fig. 5 Patient flow (* Asterix indicates children who
underwent tracheostomy)
Table 1 Diagnoses in the patient group
Diagnoses N N




Craniofacial dysostosis syndromes 13
Treacher Collins syndrome 9
Goldenhar syndrome 3
Nager acrofacial dystosis 1
Unspecified dysmorphic syndromes 23
Other rare conditions 27
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Feeding, growth and weight gain
Upon admission, 23 children were fed exclusively by
gavage; this number was reduced to 7 at discharge. The
number of children who were fully orally fed increased
from 18 to 30 during that time.
Weight, head circumference and length were deter-
mined for all infants throughout their first year of life
(n = 46), i.e. at birth (missing values for three patients),
at admission and at hospital discharge and expressed as
standard deviation scores (SDS). Median SDS scores
had been below 0 for all 3 parameters at birth, and had
deteriorated further until admission to our department.
During TPP treatment (from admission to discharge),
all 3 parameters improved, although median SDS con-
tinued to be <0 and differences were not significant
(Table 5).
Duration of hospital stay
Fourteen (25%) children stayed in hospital for less than
2 weeks, 20 (36%) for 2–4 weeks, and 22 (39%) could
only be discharged home after more than 1 month of
hospital stay.
Discussion
Upper airway obstruction and feeding problems are
major clinical problems in isolated RS and are even
more pronounced in syndromic RS. The latter patients
are more susceptible to severe and life threatening
respiratory complications than their non-syndromic
counterparts [13] and have poorer outcomes concerning
growth and development in spite of early intervention
and good control of airway and feeding problems com-
pared to children with isolated RS [22, 23].
It has been estimated that up to 80% of RS are associ-
ated with another syndrome [24]. In syndromic RS dif-
ferent pathophysiologic mechanisms may be involved,
with all 4 types of obstruction described by Sher [14]
potentially contributing to the UAO, as also confirmed
in our cohort. In our experience, the type of obstruction
determines the respective modification of the plate. If a
type 2 obstruction is observed endoscopically, a plate
with a tubular structure attached to the velar extension
may be necessary to bridge the obstruction, due to the
tongue displacing the velum posteriorly against the
pharyngeal wall. If the obstruction is due to an inward
movement of the lateral pharyngeal wall or pharyngeal
constriction (Sher types 3&4), the velar extension
requires attachment of either such a tube or a ring to
open the supra-laryngeal space (Fig. 1b-d).
No child was diagnosed with Stickler syndrome, even
if this is the most frequent syndrome described in asso-
ciation with RS. Stickler syndrome was likely underdiag-
nosed in our rather young cohort, even though all
patients were seen by a geneticist and an ophthalmolo-
gist during their hospital stay, as no routine genetic test-
ing was done for this condition.
We were able to treat UAO successfully in 51 of the
68 cases referred (75%) with syndromic RS, and 80% of
those considered candidates for TPP treatment (i.e., after
exclusion of those with central sleep apnea and laryngeal
problems), only by using the TPP and its modifications.
Five additional children were treated by TPP in associ-
ation with CPAP or high-flow nasal cannula because
they continued to suffer from a mild degree of OSA
(MOAI > 3) and we could not bring the velar extension
into a steeper position. Furthermore, 5 children (7%)
ultimately did not tolerate the TPP, which became
Table 2 Other rare conditions in the patient group
Rare conditions N Rare conditions N
Del(4q) syndrome 1 CHARGE association 4
Cat-eye syndrome 1 Popliteal pterygium syndrome 1
Cri-du-chat syndrome 1 Robinow syndrome 1
Dandy-Walker syndrome 2 Silver Russel syndrome 1
Klinefelter syndrome 1 Single incisor syndrome 2
Loeys-Dietz syndrome 1 Cerebro-costo-mandibular
syndrome
2
Miller syndrome 1 Sotos syndrome 1
Möbius sequence 1 Translocation trisomy 18 1
Mowat-Wilson syndrome 1 Trisomy 9 1
Cornelia-de-Lange
syndrome






Table 3 Pre-treatment upon admission in children completing
orthodontic treatment (N = 56)





Nassal postive pressure support 9
Tracheostomy 3
Other (adenotomy, conventional palatal palatal plate, nasal cannula
oxygen)
10
Table 4 Sleep study results (Wilcoxon rank test), shown as
median (range)
Parameter Baseline sleep study Sleep study result
at discharge
p-value
MOAI 8.5 (0.3/76.0) 1.1 (0.0/5.2) p < 0.001
DI80 2.3 (0.0/33.0) 0.0 (0/5.1) p < 0.001
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apparent after 2–3 weeks of treatment. Only 3 children
(4%) underwent tracheostomy.
Other treatment protocols proposed for RS, such
as pneumatic airway stenting with nasal CPAP or
use of a nasopharyngeal airway, provide no growth
stimulus for the mandible. This is why we added ra-
ther than replaced CPAP or high-flow nasal cannula
to TPP treatment in case of persisting UAO during
TPP treatment. Other groups reported CPAP as the
preferred treatment for UAO in RS [25], but ac-
quired maxillary hypoplasia secondary to the pro-
longed use of CPAP has been reported [26].
In infants with isolated RS, effectiveness of the TPP in
improving UAO may be explained by its velar extension
shifting the base of the tongue forward, thereby widening
the pharyngeal airway (immediate effect) [18, 19]. The
second aim of the TPP and its modifications is to push the
tongue forward and we assume that this protrusion may
induce a mandibular growth stimulus [27] (long-term
effect), although his has yet to be proven by systematic
measurements currently underway in our center.
Main reasons for non-tolerance of the plate were
repetitive impression marks and occasionally retching
or vomiting. A severe swallowing disorder, as seen in
2 of our patients with CHARGE association, or a
large tongue, as seen in two other patients with
Beckwith-Wiedemann syndrome, also seemed to pro-
hibit acceptance of the plate. In our experience a se-
vere swallowing disorder is a contraindication to TPP
treatment. In addition, the TPP proved ineffective in
2 patients presenting with laryngeal problems, which
may accompany syndromic RS, as also reported by
others [13].
We used the MOAI as our primary outcome param-
eter because, at least in infants, obstructive and mixed
apneas share the same pathophysiology [28], i.e. upper
airway narrowing, which is improved by the TPP. A po-
tential limitation of our study is that we have no center
or patient-group specific data on the inter-observer vari-
ability of the MOAI.
Airway obstruction may become more severe in the
second month of life [29]. Therefore, special attention
has to be paid also to infants with only minimal signs of
UAO shortly after birth. This might be an explanation
why 25 patients had no treatment prior to admission.
Nonetheless, we cannot exclude a later development of
UAO in some patients. Robison [30] found that 35 of 48
children with RS had OSA or sleep disordered breathing,
many of which presented after their 1st year of life and
after cleft palate repair. Late presentations of RS have
also been reported by others [31], suggesting that long-
term follow-up of this patient group, including sleep
studies, is important. We wish to stress that the palatal
plate therapy described here is also possible beyond in-
fancy, although in our experience, treatment will be
completed much faster if started in the first 1–3 postna-
tal months.
In our cohort, the proportion of children treated with
TPP (n =56) that could be fed exclusively by mouth
increased from 18 (32%) at referral to 30 (54%) at
discharge. We consider this encouraging result to be
related to the TPP, in combination with our functional
oral treatment protocol, both of which help normalizing
the tongue position by shifting it into a more anterior
position.
Airway management in children with isolated or syn-
dromic RS is still a challenge: many treatment options
are reported in the literature [32], with no consensus
about the ideal treatment. While we clearly show that
the treatment modality reported here improves airway
obstruction and failure to thrive, interpretability is lim-
ited by our retrospective study design. Also, data on
mandibular (catch-up) growth during TPP treatment are
needed. This, however, is also true for most other mo-
dalities currently applied. While such data are urgently
awaited, the effectiveness and side effects of the treat-
ment reported here may be compared to those reported
for other interventions.
Conclusion
Treatment of UAO in children with syndromic RS
with modified TPP was shown to be an effective, safe
and only minimally invasive option. It helps to avoid
more invasive interventions. Furthermore, we consider
it a causal treatment, which may induce growth of
the hypoplastic mandible and counteracts potential
oropharyngeal and muscular deficiencies. It requires
an interdisciplinary team consisting of neonatologists
trained in nasopharyngeal endoscopy, orthodontists,
pediatric sleep specialists, and speech therapists famil-
iar with orofacial regulation therapy. The nursing
team is also of outstanding importance, not least to
Table 5 Development of weight, growth and head circumference under treatment
Birth n = 43 Admittance n = 46 Discharge n = 46
Weight SDS-value –1.1 (–4.7/2.4) –1.6 (–3.5/1.7) –1.3 (–4.1/2.5)
Length SDS-value –0.9 (–4.9/2.3) –1.3 (5.4/3/2) –1.2 (–5.9/1.3)
Head circumference SDS-value –0.7 (–4.9/4.1) –1.3 (–6.1/2.3) –0.9 (–5.9/1.3)
Results are shown as median (range) SDS (standard deviation score) for patients <1 year of age only. In 3 infants, no birth weight was available from the hospital files
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train the parents in handling the plate. It has to be
pointed out that this kind of treatment is more diffi-
cult to apply in patients with syndromic compared to
isolated RS and often requires a longer hospital stay
than seen in the latter group. Long-term follow-up is
also necessary and currently underway in these
patients.
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